peptic ulcer _ clinical pharmacy
TRANSCRIPT
Peptic Ulcer Disease (PUD)
Nowras Rahhal
Damascus University – 2014
Clinical and Hospital Pharmacy
What are we going to talk about ?
Definition
Symptoms
Complications
Risk factors
Etiology
Pathophysiology
Diagnostic TestsDrug TherapyHistory
Definition
Peptic ulcer disease is characterized by the development of open sores on the
innerlining of the stomach, duodenum or esophagus.
The combination of increased hydrochloric acid and pepsin and lower GI mucosal defenses allows painful lesions to develop
Types
- Gastric
- Duodenal
- Esophageal
What Causes Ulcers?
No single cause has been found for ulcers. However, it is now clear that an ulcer is the end
result of an imbalance between digestive fluids in the stomach and duodenum. Ulcers can
be caused by :
- H pylori infection
- Drugs (NSAIDs, Clopidogrel, Potassium supplements, Chemotherapy)
- Lifestyle factors (Smoking, Alcohol and Caffeine)
- Severe physiologic stress (Burns, CNS trauma, surgery, and severe medical illness)
- Hypersecretory states (uncommon)
- Genetic factors
H. pylori
• H pylori is most common
cause of PUD
• Secretes urease →convert urea to ammonia
• Produces alkaline environment enabling survival in stomach.
• Estimated 70% of Asians H
pylori (+)
Why NSAIDs
Cause PUD? Risk factors:
previous PUD, Elder, female sex, high doses or
combinations of NSAIDs, long-term NSAID use,
use of anticoagulants.
H pylori and NSAIDs are synergistic.
Ulcers associated with H. pylori : more often in
duodenum, often superficial, less severe GI
bleeding.
Ulcers associated with NSAIDs : more often in
stomach, often deep more severe, GI
bleeding.
• NSAIDs block the function
of COX-1, which is essential for the production of
prostaglandins.
• COX-2 selective anti-
inflammatories )Celecoxib) preferentially inhibit cox-2,
which is less essential in the
gastric mucosa.
What Are the Symptoms and Complications?
An ulcer may or may not have symptoms.
When symptoms occur, they may include:
1. Dyspepsia.
2. Bloating and discomfort.
3. Heartburn.
4. Nausea or vomiting.
5. unexplained weight loss.
In severe cases, symptoms can include:
1. Dark or black stool.
2. Vomiting blood.
3. Severe pain in the mid to upper abdomen.
Complications of peptic ulcer:
1. Gastrointestinal bleeding .
2. Perforation.
3. Perforation and penetration.
4. Gastric outlet obstruction.
5. Cancer.
Gastric Ulcers Duodenal Ulcers Esophageal Ulcers
Pain occurs 1-2 hours
after meals.
Pain occurs 2-4 hours
after meals.
Pain when swallowing
Pain usually does not
wake patient.
Pain wakes up patient. -
Accentuated by
ingestion of food.
Pain relieved by food. -
Risk for malignancy. Very little risk for
malignancy.
-
Pathophysiology
Peptic ulcers are defects in the gastric or duodenal mucosa that extend through the
muscularis mucosa.
Main defense Systems :
1. Mucous layer (First line of defense)
2. Bicarbonate
3. Prostaglandins (PGE)
Additional mechanisms :
1. Ion pumps
2. Mucosal blood flow
3. Healthy cells migrate to the site of injury
PEPTIC ULCER DISEASE
13
IMBALANCE
FACTORS
THAT PROTECT
AGAINST
ACIDITY
FACTORS
THAT INCREASE
ACID
SECRETIO
N
Acid
Pepsin
Bile acids
NSAIDs
H. pylori
Alcohol
Pancreatic enzymes Mucus
bicarbonate layer
Blood flow
cell renewal
Prostaglandins
tight intercellularjunctions
Diagnostic Tests
Laboratory
CBC: Rule out anemia.
Other lap test need (e.g.) Amylase ,Serum gastrin, gastric fluid analysis.
Endoscopy.
Upper GI radiography series (alternative).
Diagnostic test for H. pylori: Noninvasive
Urea breath test (UBT)
Stool antigen test (SAT)
Invasive
Biopsy urease test
Rapid urease test
Primary
treatment Goals
Relieve pain and reduce anxiety.
Relieve dyspepsia and heal the ulcer.
Prevent complications / recurrence.
What are the non-drug treatments?
The following lifestyle modifications can alleviate the symptoms of PUD:
Eat smaller, more frequent meals.
Avoid fatty foods, spicy foods, and coffee.
Reduce stress.
Stop smoking.
Limit alcohol consumption.
Limit NSAID use if possible.
Avoid reclining after meals.
Lose weight.
Drug Therapy
Drugs for reduction of acid secretion:
Proton Pump Inhibitors (PPI): Omeprazole, Lansoprazole, Rabeprazole, Pantoprazole.
• PPIs are pro-drugs that are activated by acid.
• Acid secretion is inhibited by inactivation of the H +/K+ ATPase, or acid pump.
• Used before breakfast
• Side effects included GI disturbances, headache.
H2 receptor antagonists (H2RAs): Cimetidine, Ranitidine, Nizatidine,Famotidine.
• reversibly inhibit gastric acid secretion by competitively binding the histamine
receptor.
• Used in the evening or before sleeping.
• Side effects Diarrhoea , headache, dizziness and rash
Prostaglandin analogues: Misoprostol
• Do Not use with pregnancy or inflammatory bowel disease.
• Side effects: Diarrhoea, abdominal pain, nausea, vomiting, rashes,
dizziness.• Cytoprotective effect.
o Drugs to neutralize gastric acid (antacids): Aluminum + Magnesium. Hydroxide, Calcium carbonate
Sodium bicarbonate Sodium citrate
Sucralfate
o Anti H.pylori drugs:Amoxicillin Clarithromycin Tetracycline, Metronidazole
o Antidiarrheal: (Bismuth subsalicylate) may have antisecretory and antimicrobial
action
Treatment Guideline:
Patients testing positive for H. pylori
should undergo eradication therapy for 10-14 days.
1. First line treatment: Triple therapy of PPI bid, Amoxicillin bid and clarithromycin500mg bid
• If patients are allergic to penicillin then metronidazole 500mg bid is substituted for amoxicillin.
2. Second line treatment (if triple therapy fails): Qyadruple therapy of PPI bid, bismuth subsalicylate bid, tetracycline 500mg qid, and metronidazole 500mg tid.
Patients testing negative for H. pylori
should undergo a 4-8 week antisecretory
trial using a PPI or an H2RA. If the trial fails,
an EGD (Esophagogastroduondonscopy)
is performed.
What if patients had to take NSAIDs?
To prevent NSAID-induced ulcers, pharmacists can make the following treatment
recommendations based on the patient's risk profile:
Low risk (no risk factors): use lowest effective dose of NSAID
Moderate risk (1-2 risk factors): use lowest effective dose of NSAID + Misoprostol, NSAID
+ PPI or H2RA or use a COX2 inhibitor
High risk (multiple risk factors or patients using Concomitant steroids, anticoagulants, or
low-dose aspirin):
Concomitant Steroids: COX-2 inhibitor alone
Concomitant Warfarin: COX-2 inhibitor + misoprostol
Concomitant Aspirin: COX - 2 inhibitor + PPI or misoprostol
History of disease
Helicobacter pylori was rediscovered in 1982 by two Australian scientists, Robin Warren
and Barry J. Marshall as a causative factor for ulcers.
In 2005, Dr. Marshall and Dr. Warren awarded the Nobel Prize in Physiology or Medicine for their discovery of the bacterium Helicobacter pylori and its role in gastritis
and peptic ulcer disease